Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | POLB | P06746 | 3/20 | 0.58 |
| ▸ | NT5E | P21589 | 1/20 | 0.56 |
| ▸ | P2RY6 | Q15077 | 2/20 | 0.53 |
| ▸ | P2RY2 | P41231 | 1/20 | 0.53 |
| ▸ | P2RY4 | P51582 | 1/20 | 0.53 |
| ▸ | ENPP1 | P22413 | 5/20 | 0.51 |
| ▸ | P2RY1 | P47900 | 3/20 | 0.51 |
| ▸ | P2RX1 | P51575 | 2/20 | 0.51 |
| ▸ | P2RX3 | P56373 | 2/20 | 0.51 |
| ▸ | P2RY11 | Q96G91 | 1/20 | 0.51 |
| ▸ | P2RX4 | Q99571 | 1/20 | 0.51 |
| ▸ | P2RY12 | Q9H244 | 1/20 | 0.49 |
| ▸ | DTYMK | P23919 | 4/20 | 0.49 |
| ▸ | RNASEL | Q05823 | 1/20 | 0.48 |
| ▸ | P2RX2 | Q9UBL9 | 1/20 | 0.47 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30848914 | 1.00 | POLB (0.58) | POLBNT5EP2RY6P2RY2P2RY4 | |
| SCHEMBL30279681 | 0.92 | NT5E (0.60) | POLBNT5EP2RY6P2RY2P2RY4 | |
| SCHEMBL12932286 | 0.89 | NT5E (0.67) | POLBNT5EP2RY6P2RY2P2RY4 | |
| SCHEMBL345288 | 0.89 | NT5E (0.67) | POLBNT5EP2RY6P2RY2P2RY4 | |
| SCHEMBL4820794 | 0.89 | NT5E (0.67) | POLBNT5EP2RY6P2RY2P2RY4 | |
| SCHEMBL17117823 | 0.89 | NT5E (0.67) | POLBNT5EP2RY6P2RY2P2RY4 | |
| SCHEMBL29400356 | 0.89 | NT5E (0.67) | POLBNT5EP2RY6P2RY2P2RY4 | |
| SCHEMBL8079921 | 0.87 | POLB (0.56) | POLBNT5EP2RY6P2RY2P2RY4 | |
| SCHEMBL12729466 | 0.87 | POLB (0.52) | POLBNT5EP2RY6P2RY2P2RY4 | |
| SCHEMBL17833848 | 0.87 | POLB (0.52) | POLBNT5EP2RY6P2RY2P2RY4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 142 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20140170689-A1 | Modified Diguanylate Cyclase-Phosphodiesterase and Method for Enzymatic Production of Cyclic-diGMP | THE RESEARCH FOUNDATION FOR THE STATE UNIVERSITY OF NEW YORK (US) | 2014-06-19 | — | — | US | claimed |
| US-10662485-B2 | Bioagent detection oligonucleotides | IBIS BIOSCIENCES, INC. (US) | 2020-05-26 | — | — | US | disclosed |
| US-9970061-B2 | Bioagent detection oligonucleotides | IBIS BIOSCIENCES, INC. (US) | 2018-05-15 | — | — | US | disclosed |
| US-9758840-B2 | Parasite detection via endosymbiont detection | IBIS BIOSCIENCES, INC. (US) | 2017-09-12 | — | — | US | disclosed |
| US-9719083-B2 | Bioagent detection methods | IBIS BIOSCIENCES, INC. (US) | 2017-08-01 | — | — | US | disclosed |
| US-20160325283-A1 | BIOAGENT DETECTION SYSTEMS, DEVICES, AND METHODS | IBIS BIOSCIENCES INC (US) | 2016-11-10 | — | — | US | disclosed |
| US-9447462-B2 | Methods for concurrent identification and quantification of an unknown bioagent | IBIS BIOSCIENCES, INC. (US) | 2016-09-20 | — | — | US | disclosed |
| EP-2462244-B1 | NON-MASS DETERMINED BASE COMPOSITIONS FOR NUCLEIC ACID DETECTION | IBIS BIOSCIENCES INC (US) | 2016-07-20 | — | — | EP | disclosed |
| US-9393564-B2 | Bioagent detection systems, devices, and methods | IBIS BIOSCIENCES, INC. (US) | 2016-07-19 | — | — | US | disclosed |
| US-20160108461-A1 | TARGETED WHOLE GENOME AMPLIFICATION METHOD FOR IDENTIFICATION OF PATHOGENS | IBIS BIOSCIENCES, INC. | 2016-04-21 | — | — | US | disclosed |
| US-20060259249-A1 | Rapid identification of microbial agents | IBIS BIOSCIENCES, INC. | 2006-11-16 | — | — | US | disclosed |
| US-20060205040-A1 | Compositions for use in identification of adventitious viruses | IBIS BIOSCIENCES, INC. | 2006-09-14 | — | — | US | disclosed |
| WO-2006094238-A2 | COMPOSITIONS FOR USE IN IDENTIFICATION OF ADVENTITIOUS VIRUSES | ISIS PHARMACEUTICALS, INC. (US) | 2006-09-08 | — | — | WO | disclosed |
| WO-2006071241-A2 | COMPOSITIONS FOR USE IN IDENTIFICATION OF BACTERIA | ISIS PHARMACEUTICALS, INC. (US) | 2006-07-06 | — | — | WO | disclosed |
| US-20060057605-A1 | Compositions for use in identification of viral hemorrhagic fever viruses | ISIS PHARMACEUTICALS, INC. (US) | 2006-03-16 | — | — | US | disclosed |
| WO-2005098047-A2 | COMPOSITIONS FOR USE IN IDENTIFICATION OF BACTERIA | ISIS PHARMACEUTICALS, INC. (US) | 2005-10-20 | — | — | WO | disclosed |
| WO-2005094421-A2 | METHODS FOR CONCURRENT IDENTIFICATION AND QUANTIFICATION OF AN UNKNOWN BIOAGENT | ISIS PHARMACEUTICALS, INC. (US) | 2005-10-13 | — | — | WO | disclosed |
| WO-2005091971-A2 | COMPOSITIONS FOR USE IN IDENTIFICATION OF ALPHAVIRUSES | ISIS PHARMACEUTICALS, INC. (US) | 2005-10-06 | — | — | WO | disclosed |
| WO-2005092059-A2 | COMPOSITIONS FOR USE IN IDENTIFICATION OF VIRAL HEMORRHAGIC FEVER VIRUSES | ISIS PHARMACEUTICALS, INC. (US) | 2005-10-06 | — | — | WO | disclosed |
| WO-2005089128-A2 | RAPID IDENTIFICATION OF MICROBIAL AGENTS | ISIS PHARMACEUTICALS, INC. (US) | 2005-09-29 | — | — | WO | disclosed |